CombiCyte™
Advanced Cell Therapy for Wound Healing||Revolutionize Wound Healing
Immune System Modulation
CombiCyte™ utilizes a unique approach to wound healing by modulating the immune system.
Immune System Modulation
This technology enhances the body's natural healing processes, thereby addressing the underlying issues that contribute to slow wound healing.
Active Cytokine Delivery
CombiCyte™ deploys specialized cells with the capability to deliver active cytokines directly to the wound site.
Active Cytokine Delivery
These living cellular therapeutics accelerate the wound healing cascade, triggering multiple parallel pathways that promote faster and more effective healing compared to single-growth-factor therapies.
Versatile Biomaterial Delivery
CombiCyte™ employs a flowable, settable biomaterial as a carrier for the living cytokine factories.
Versatile Biomaterial Delivery
This biomaterial is highly adaptable and can be easily applied to the wound. It not only protects the wound during the healing process but also allows for precise control and targeted delivery of therapeutic factors.
Unveiling the Future of Wound Healing
At Curada Bio, we are proud to introduce CombiCyte™, an innovative and groundbreaking solution in the field of wound healing. Chronic wounds, such as diabetic foot ulcers and pressure sores, pose a significant healthcare challenge, affecting millions of individuals and accounting for a substantial portion of healthcare expenditures annually.
CombiCyte™ represents a paradigm shift in the way we approach wound care. Our groundbreaking technology is designed to address the unmet medical need for refractory chronic wounds that often do not respond to conventional treatments. These wounds can lead to severe complications, including infections, amputations, and even increased mortality rates.
Benefits of CombiCyte™
At Curada Bio, our mission is to revolutionize wound healing, and CombiCyte™ embodies our commitment to providing patients and healthcare professionals with the most advanced and effective solution for chronic wounds. We understand that addressing the complex nature of these wounds requires an innovative approach that goes beyond conventional treatments. CombiCyte™ offers a range of unparalleled benefits that set it apart from traditional wound care methods.
Rapid Wound Closure
CombiCyte™ accelerates the healing process, leading to faster wound closure with minimized scar formation. With our innovative approach to cytokine delivery, we anticipate patients will experience significantly reduced healing times compared to conventional therapies.
Broadly Applicable
CombiCyte™ is not limited to one type of wound. It is anticipated to offer versatility by addressing a range of indications, from diabetic foot ulcers to pressure and venous ulcers and traumatic muscle wounds. This broad application will make it a comprehensive choice for wound care professionals.
Enhanced Receptivity
Physicians have shown a high level of interest in CombiCyte™ as a first-line therapy for refractory chronic wounds. The technology’s adaptability to different patient needs and wound types enhances interest among healthcare providers.
Lower Healthcare Costs
We believe that the accelerated wound healing CombiCyte™ will be able to facilitate will translate into significant cost savings for both patients and healthcare systems. Shorter treatment durations and improved outcomes lead to lower healthcare expenditures.
CombiCyte™ Platform
At Curada Bio, our mission is to revolutionize wound healing, and CombiCyte™ embodies our commitment to providing patients and healthcare professionals with the most advanced and effective solution for chronic wounds. We understand that addressing the complex nature of these wounds requires an innovative approach that goes beyond conventional treatments. CombiCyte™ offers a range of unparalleled benefits that set it apart from traditional wound care methods.
